Deerfield Management Company, L.P. (Series C) Editas Medicine, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $21.4 Million - $48.8 Million	-538,721 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $12.2 Million - $38 Million	-450,120 Reduced 45.52%	538,721 $37.8 Million
Q3 2020 Nov 16, 2020	SELL	$28.06 - $37.16 $4.77 Million - $6.32 Million	-170,000 Reduced 14.67%	988,841 $27.7 Million
Q1 2018 May 15, 2018	SELL	$29.84 - $44.08 $16.4 Million - $24.3 Million	-550,559 Reduced 32.21%	1,158,841 $38.4 Million
Q3 2017 Nov 13, 2017	BUY	$15.81 - $24.01 $27 Million - $41 Million	1,709,400	1,709,400 $41 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$15.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$13.3 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$9.75 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$6.67 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$4.9 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $137M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account